How Biological Assets Are Measured and Reported under IFRS 41 and ASC 905

Biological assets represent living plants and animals held for agricultural production, such as livestock, vineyards, or timber plantations. Their measurement introduces a dynamic challenge in accounting because their value changes as they grow, reproduce, or deteriorate. Under IFRS (IAS 41 – Agriculture) and US GAAP (ASC 905 – Agriculture), biological assets are measured to reflect biological transformation—capturing growth and productivity in real time rather than at historical cost.

·····

.....

How biological assets arise.

Biological assets arise when a company engages in agricultural activity aimed at producing goods or generating biological transformation for sale or further processing. These include animals raised for meat, dairy, or breeding; trees grown for lumber; or crops cultivated for harvest.

Examples include:

• Cattle herds for milk or beef production.

• Timber plantations for future harvesting.

• Vineyards producing grapes for wine.

• Aquaculture farms raising fish or shellfish.

In all cases, the key condition is that the asset is alive and subject to measurable growth or degeneration, which creates accounting complexity because its fair value changes continuously.

·····

.....

Measurement under IFRS 41.

IAS 41 requires that biological assets be measured at fair value less costs to sell, both at initial recognition and at each subsequent reporting date.This model reflects the economic benefits that arise from biological transformation — such as growth, procreation, or quality improvement — rather than waiting until harvest or sale to recognize gains.

If fair value cannot be reliably measured (a rare exception allowed at initial recognition), the asset is measured at cost less accumulated depreciation and impairment losses until fair value becomes measurable.

Example:A livestock company purchases 100 young cattle for 200,000. At year-end, an independent valuation shows the herd’s fair value increased to 240,000, with estimated selling costs of 10,000. The company records a 30,000 unrealized gain in profit or loss.

Journal entries:

Initial recognition

• Debit: Biological Assets (Livestock) 200,000

• Credit: Cash 200,000

At year-end revaluation (fair value adjustment)

• Debit: Biological Assets (Livestock) 30,000

• Credit: Gain on Fair Value Change 30,000

Fair value adjustments under IFRS 41 are always recognized in profit or loss, never in other comprehensive income.

·····

.....

Measurement under US GAAP (ASC 905).

ASC 905 does not require a fair value model. Biological assets—referred to as productive or consumable agricultural assets—are generally measured at cost less accumulated depreciation or depletion, consistent with the historical cost principle.

Under US GAAP:

• Costs incurred to grow or raise assets (feed, fertilizer, maintenance) are capitalized as part of inventory or fixed asset cost.

• Revenue is recognized upon harvest or sale, not during biological transformation.

• Livestock held for breeding or milk production may be treated as depreciable property, plant, and equipment (PPE) rather than inventory.

Example:If a timber company spends 500,000 developing a plantation, these costs accumulate as an asset. No gains are recorded until harvest revenue is realized, contrasting IFRS’s ongoing fair value recognition.

Journal entries (simplified):

During development

• Debit: Biological Assets (Timber Plantation) 500,000

• Credit: Cash 500,000

At harvest/sale

• Debit: Cost of Goods Sold xxx

• Credit: Biological Assets xxx

• Debit: Cash/Receivables xxx

• Credit: Revenue xxx

This approach produces smoother income recognition but less real-time reflection of biological transformation.

·····

.....

Comparative table: IFRS 41 vs ASC 905.

Aspect	IFRS (IAS 41 – Agriculture)	US GAAP (ASC 905 – Agriculture)
Measurement basis	Fair value less costs to sell	Historical cost (accumulated cost)
Revaluation frequency	At each reporting date	None – cost basis maintained
Recognition of changes	Gains/losses in profit or loss	Deferred until sale or harvest
Bearer plants	Accounted under IAS 16 (PPE)	Treated as depreciable assets
Produce at harvest	Measured at fair value at harvest (basis for inventory)	Measured at cost; included in inventory
Disclosure focus	Methods, assumptions, reconciliation of fair values	Cost accumulation and harvest yields

Under IFRS, biological transformation directly affects profit and loss, introducing volatility but higher transparency. Under US GAAP, stability in earnings is achieved at the expense of immediacy and valuation accuracy.

·····

.....

Presentation and disclosures.

Under IFRS, biological assets are presented as a separate line item on the balance sheet, typically within non-current assets unless harvested within 12 months. Entities must disclose:

• A reconciliation of changes in carrying amounts.

• The methods and assumptions used in determining fair value.

• Quantitative data about physical changes (e.g., herd growth, yield increases).

• Restrictions on title or use of assets.

Under US GAAP, biological assets are usually presented within inventory or property, plant, and equipment, depending on their use. Disclosures focus on cost policies, harvest timing, and valuation methods used for depletion or depreciation.

Example presentation (IFRS):

Assets	Amount (USD)
Current Assets:
Inventory	420,000
Accounts Receivable	180,000
Cash and Cash Equivalents	90,000
Non-Current Assets:
Property, Plant, and Equipment	1,500,000
Biological Assets	240,000

This reflects ongoing fair value adjustments, giving investors insight into productivity trends.

·····

.....

Impact on financial performance and analysis.

Under IFRS, fair value gains and losses from biological assets directly influence operating profit, increasing volatility but aligning financial results with physical production cycles. Analysts interpret these fluctuations as indicators of biological efficiency rather than financial instability.

Under US GAAP, results remain smoother, as changes are deferred until harvest. However, analysts often rely on management commentary or non-GAAP measures to understand biological performance during the period.

Fair value accounting also affects ratios:

• Asset Turnover: Higher under IFRS due to periodic revaluations.

• Earnings Volatility: Greater under IFRS because unrealized gains/losses flow through profit or loss.

• Return on Assets (ROA): Potentially distorted if biological assets fluctuate sharply in value.

Both frameworks require careful reconciliation between physical yield metrics and accounting outcomes to ensure meaningful performance evaluation.

·····

.....

Operational considerations.

Accounting for biological assets demands reliable valuation models, access to market data, and continuous monitoring. Independent appraisals, actuarial estimates, and commodity price indices often serve as fair value inputs.

Management must balance transparency with stability: while IFRS offers real-time reflection of agricultural productivity, it may introduce unpredictable profit swings that complicate budgeting and performance targets.

In industries like forestry, aquaculture, and livestock, accurate biological asset measurement supports better resource allocation, sustainability reporting, and investment analysis—transforming living assets into measurable economic indicators.

·····

.....

FOLLOW US FOR MORE.

DATA STUDIOS

.....[datastudios.org]